FBU-25181-85632
3 vaccinations
3 coded responses
15 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 625 / IL
- Registered
- 2020-12-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-30
Registered in v-safe
-
2020-12-30
Dose 1 — Moderna
-
2020-12-30
Survey response — day 0, dose 1MedDRA: Hyperhidrosis — Feeling: Fair · Site: Pain · ChillsFree text: SweatingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2020-12-31
- 2021-01-02
- 2021-01-03
- 2021-01-07
- 2021-01-13
- 2021-01-21
-
2021-01-26
Dose 2 — Moderna
-
2021-09-08
Dose 3 — Moderna
-
2021-09-10
Survey response — days 1–6 daily, dose 3MedDRA: Injection site induration, Injection site swelling — Feeling: Poor · Site: Pain, Redness, Swelling, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesFree text: Swelling firmness at injection siteMedDRA releases: 2024-11 · check-in free text available
-
2021-09-11
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Redness, Swelling, Itching · NoneAdult check-in
-
2021-09-13
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Redness, Swelling · NoneAdult check-in
- 2021-09-14
- 2021-09-15
- 2021-09-22
- 2021-09-29
-
2021-10-20
Survey response — day 42, dose 3MedDRA: Diarrhoea, Nausea, Pyrexia, Vomiting — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Nausea Vomiting Diarrhea FeverMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-30 | Moderna | |
| 2 | 2021-01-26 | Moderna | No |
| 3 | 2021-09-08 | Moderna | No |
Free text
Release 1 — day 0, dose 1
Systemic reaction (other): Sweating
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): Swelling firmness at injection site
Release 10 — day 42, dose 3
Symptoms: Nausea Vomiting Diarrhea Fever
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Diarrhoea | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Vomiting | · | · | ✓ |
| SRO | Hyperhidrosis | ✓ | ✓ | ✓ |
| SRO | Injection site induration | · | · | ✓ |
| SRO | Injection site swelling | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release